Sep 12, 2023 7:45 am EDT Kane Biotech Announces Closing of Fully Subscribed Private Placement Offering and Amendments to its Credit Facility
Aug 22, 2023 7:30 am EDT Kane Biotech to Release Second Quarter 2023 Financial Results on Aug 29, 2023 – Conference Call to Follow
Aug 3, 2023 7:45 am EDT Kane Biotech Announces Private Placement Offering and Proposed Amendments to its Credit Facility
Aug 2, 2023 7:30 am EDT Kane Biotech Engages Research Capital to Conduct Strategic Review of STEM Animal Health
May 25, 2023 10:38 am EDT Kane Biotech Announces FDA 510(k) Clearance for its coactiv+™ Antimicrobial Wound Gel
May 18, 2023 4:05 pm EDT Kane Biotech to Release First Quarter 2023 Financial Results on May 25, 2023 – Conference Call to Follow
